ARS Pharmaceuticals: Lawsuits And Cash Burn Are Priced In, Yet The Stock Keeps Falling
· seekingalpha.com
ARS Pharmaceuticals' neffy faces slow adoption and insurance hurdles but shows potential for significant market share and revenue. Read why SPRY stock is a Buy.
ARS Pharmaceuticals, Inc. ( SPRY ) is an early commercial-stage company that has a targeted platform approach. What this means is that one delivery system (an i...